Atrial acetylcholinesterase activity in various heart diseases of man

Cardiology
|January 1, 1979
PubMed

Insights

The human atrial myocardium has a rich network of cholinergic nerves. Acetylcholinesterase activity in these nerves is not a primary factor in parasympathetic dysfunction seen in heart conditions, including heart failure.

Area of Science:

  • Cardiovascular Histology
  • Neuroanatomy
  • Cardiac Physiology

Background:

  • The intrinsic nervous system of the human atrium plays a crucial role in cardiac function.
  • Understanding the distribution and activity of cholinergic nerves is vital for comprehending cardiac autonomic regulation.
  • Previous studies have suggested alterations in cardiac innervation in various heart diseases.

Purpose of the Study:

  • To investigate the distribution and activity of acetylcholinesterase enzyme in the human atrial myocardium.
  • To characterize the intrinsic nervous apparatus within the atrial tissue across different cardiac conditions.
  • To determine if acetylcholinesterase activity correlates with parasympathetic abnormalities in heart disease.

Main Methods:

  • Histochemical analysis of acetylcholinesterase distribution in atrial myocardial specimens.
  • Examination of tissue from patients undergoing cardiac surgery for various conditions: atrial septal defect, ischemic heart disease, valvular disease, and congestive heart failure.
  • Microscopic assessment of nerve net patterns and presence of nerve cells.

Main Results:

  • A rich, parenchymatous, three-dimensional nerve net of acetylcholinesterase-positive axons was consistently observed in the human atrial myocardium.
  • Small groups of acetylcholinesterase-positive nerve cells were identified in some specimens.
  • No significant differences in acetylcholinesterase distribution or nervous apparatus pattern were found among the different patient groups.
  • Non-specific cholinesterase activity was absent in all specimens.

Conclusions:

  • The human atrial myocardium is abundantly supplied with intrinsic cholinergic (post-ganglionic vagal) axons.
  • Acetylcholinesterase activity is unlikely to be a primary determinant of parasympathetic abnormalities observed in cardiac diseases, particularly in myocardial pump failure.

Related Concept Videos

Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...